These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4512618)

  • 1. Aggregation of human platelets by purified porcine and bovine antihaemophilic factor.
    Forbes CD; Prentice CR
    Nat New Biol; 1973 Jan; 241(109):149-50. PubMed ID: 4512618
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition and reversal of ristocetin - induced platelet aggregation.
    Howard MA
    Thromb Res; 1975 Jun; 6(6):489-99. PubMed ID: 239463
    [No Abstract]   [Full Text] [Related]  

  • 3. Aggregation of human platelets by commercial preparations of bovine and porcine antihaemophilic globulin.
    Forbes CD; Barr RD; McNicol GP; Douglas AS
    J Clin Pathol; 1972 Mar; 25(3):210-7. PubMed ID: 5062992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human platelet aggregation by plasmin digests of human factor VIII.
    Donati MB; de Gaetano G; Vermylen J; Verstraete M
    Blood; 1973 Nov; 42(5):749-51. PubMed ID: 4270477
    [No Abstract]   [Full Text] [Related]  

  • 5. Aggregation of human platelets by bovine or human factor VIII: role of carbohydrate side chains.
    Vermylen J; Donati MB; De Gaetano G; Verstraete M
    Nature; 1973 Jul; 244(5412):167-8. PubMed ID: 4583498
    [No Abstract]   [Full Text] [Related]  

  • 6. Defective ristocetin and bovine factor VIII-induced platelet aggregation in normal rats.
    de Gaetano G; Donati MB; Reyers-Degli Innocenti I; Roncaglioni MC
    Experientia; 1975 Apr; 31(4):500-2. PubMed ID: 1120536
    [No Abstract]   [Full Text] [Related]  

  • 7. The interaction of bovine factor VIII with human platelets.
    Kirby EP; Mills DC
    J Clin Invest; 1975 Aug; 56(2):491-502. PubMed ID: 807600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human platelet aggregation by plasmin digests of human and bovine fibrinogen preparations: role of contaminating factor VIII-related material.
    Culasso DE; Donati MB; de Gaetano G; Vermylen J; Verstraete M
    Blood; 1974 Aug; 44(2):169-75. PubMed ID: 4277539
    [No Abstract]   [Full Text] [Related]  

  • 9. Dissociation between human platelet agglomerating activity and factor VIII procoagulant activity of bovine plasma preparations by chemical treatment. I. Effect of neuraminidase.
    Levy-Toledano S; Caen JP; Halmos T; Mester L
    Pathol Biol (Paris); 1973 Nov; 21():Suppl:60-2. PubMed ID: 4587019
    [No Abstract]   [Full Text] [Related]  

  • 10. Separation of human factor VIII activity from the von Willebrand's antigen and ristocetin platelet aggregating activity.
    Baugh R; Brown J; Sargeant R; Hougie C
    Biochim Biophys Acta; 1974 Dec; 371(2):360-7. PubMed ID: 4433572
    [No Abstract]   [Full Text] [Related]  

  • 11. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease.
    Bouma BN; Wiegerinck Y; Sixma JJ; Van Mourik JA; Mochtar IA
    Nat New Biol; 1972 Mar; 236(65):104-6. PubMed ID: 4112547
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Experimental model for von Willebrand's disease.
    Meyer D; Jenkins CS; Dreyfus M; Larrieu MJ
    Nature; 1973 Jun; 243(5405):293-4. PubMed ID: 4542702
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparation and properties of bovine factor VIII (antihemophilic factor).
    Vehar GA; Davie EW
    Biochemistry; 1980 Feb; 19(3):401-10. PubMed ID: 7356933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity.
    Weiss HJ; Hoyer IW
    Science; 1973 Dec; 182(4117):1149-51. PubMed ID: 4127287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a form of bovine factor VIII which does not aggregate human platelets.
    Kirby EP
    Thromb Haemost; 1981 Aug; 46(2):479-84. PubMed ID: 6795738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation of bovine Factor VIII-related antigen (platelet aggregating factor) from bovine antihemophilic factor.
    Brown JE; Baugh RF; Sargeant RB; Hougie C
    Proc Soc Exp Biol Med; 1974 Dec; 147(3):608-11. PubMed ID: 4475426
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation of plasma co-factor in adenosine diphosphate-induced aggregation of bovine platelets.
    Nishimura Y; Yamada Y; Ito M; Takenaka O; Inada Y
    FEBS Lett; 1975 Mar; 51(1):171-3. PubMed ID: 1123049
    [No Abstract]   [Full Text] [Related]  

  • 20. Dissociation between human platelet agglomerating activity and factor VIII procoagulant activity of bovine plasma preparations by chemical treatment. II. Effect of periodate oxidation.
    Mello Périssé AC; Soria J; Soria C; Mester L
    Pathol Biol (Paris); 1973 Nov; 21():Suppl:63-5. PubMed ID: 4357696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.